| Assets | $68.35M |
| Expense Ratio | 2.54% |
| PE Ratio | n/a |
| Shares Out | 4.39M |
| Dividend (ttm) | $2.72 |
| Dividend Yield | 17.18% |
| Ex-Dividend Date | Jun 25, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| Volume | 32 |
| Open | 15.84 |
| Previous Close | 15.57 |
| Day's Range | 15.84 - 15.84 |
| 52-Week Low | 12.71 |
| 52-Week High | 27.52 |
| Beta | 1.20 |
| Holdings | 23 |
| Inception Date | Feb 7, 2023 |
About SURI
Fund Home PageThe Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities SURI was launched on Feb 7, 2023 and is issued by Simplify.
Top 10 Holdings
84.30% of assets| Name | Symbol | Weight |
|---|---|---|
| Plains GP Holdings, L.P. | PAGP | 34.76% |
| Akero Therapeutics, Inc. | AKRO | 10.33% |
| Milestone Pharmaceuticals Inc. | MIST | 6.94% |
| Abeona Therapeutics Inc. | ABEO | 5.82% |
| Phathom Pharmaceuticals, Inc. | PHAT | 5.53% |
| Achieve Life Sciences, Inc. | ACHV | 4.98% |
| Cash | Cash | 4.45% |
| Delcath Systems, Inc. | DCTH | 4.18% |
| TELSAT 6.5 10/15/27 144A Corp | TELSAT.6.5 10.15.27 144A | 4.00% |
| Applied Therapeutics, Inc. | APLT | 3.31% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 25, 2025 | $0.680 | Jun 30, 2025 |
| Mar 26, 2025 | $0.680 | Mar 31, 2025 |
| Dec 23, 2024 | $0.680 | Dec 31, 2024 |
| Sep 25, 2024 | $0.680 | Sep 30, 2024 |
| Jun 25, 2024 | $1.250 | Jun 28, 2024 |
| Mar 25, 2024 | $0.680 | Mar 28, 2024 |
Performance
SURI had a total return of -22.96% in the past year, including dividends. Since the fund's inception, the average annual return has been -2.24%.
News
Simplify Propel Opportunities ETF: Healthcare Likely To Rise Again In FY24 And Beyond
The Simplify Propel Opportunities ETF (SURI) is a healthcare-based fund that provides exposure to global fixed income and equity markets in the healthcare sector. SURI has a since-inception return of ...
